Technical Analysis for ALQA - Alliqua, Inc.

Grade Last Price % Change Price Change
grade B 2.67 -3.61% -0.10
ALQA closed down 3.61 percent on Friday, March 22, 2019, on 45 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Down
See historical ALQA trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 21 20 DMA Support Bullish -3.61%
Mar 21 Wide Bands Range Expansion -3.61%
Mar 20 20 DMA Support Bullish -2.55%
Mar 20 Calm After Storm Range Contraction -2.55%
Mar 20 Wide Bands Range Expansion -2.55%
Mar 19 MACD Bearish Signal Line Cross Bearish -0.37%
Mar 19 20 DMA Support Bullish -0.37%
Mar 19 1,2,3 Pullback Bullish Bullish Swing Setup -0.37%

Older signals for ALQA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Alliqua, Inc., a biopharmaceutical company, focuses on the development, manufacture, and distribution of proprietary transdermal wound care and drug delivery technologies. The company offers water content, electron beam cross-linked, and aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Its products include SilverSeal, a hydrogel wound dressing with silver coated fibers; and Hydress, an over-the-counter hydrogel wound dressing. The company's products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. It also focuses on developing proprietary products for wound care dressings, and a transdermal delivery technology platform to deliver drugs and other beneficial ingredients through the skin. In addition, the company develops HepaMate, an extracorporeal temporary liver support system designed to provide whole liver function to patients with acute or severe liver failure. Alliqua, Inc. is headquartered in Langhorne, Pennsylvania.
Medicine Biopharmaceutical Clinical Medicine Health Sciences Dosage Forms Drug Delivery Drug Delivery Technologies Physical Chemistry Transdermal
Is ALQA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.24
52 Week Low 1.55
Average Volume 178,687
200-Day Moving Average 2.2282
50-Day Moving Average 2.4672
20-Day Moving Average 2.7085
10-Day Moving Average 2.82
Average True Range 0.2557
ADX 58.31
+DI 28.6401
-DI 7.6476
Chandelier Exit (Long, 3 ATRs ) 2.8829
Chandelier Exit (Short, 3 ATRs ) 2.9471
Upper Bollinger Band 3.2767
Lower Bollinger Band 2.1403
Percent B (%b) 0.47
BandWidth 41.956803
MACD Line 0.0982
MACD Signal Line 0.1288
MACD Histogram -0.0305
Fundamentals Value
Market Cap 13.38 Million
Num Shares 5.01 Million
EPS -11.16
Price-to-Earnings (P/E) Ratio -0.24
Price-to-Sales 0.76
Price-to-Book 0.52
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.92
Resistance 3 (R3) 2.95 2.88 2.88
Resistance 2 (R2) 2.88 2.82 2.87 2.87
Resistance 1 (R1) 2.78 2.78 2.75 2.75 2.85
Pivot Point 2.71 2.71 2.70 2.70 2.71
Support 1 (S1) 2.61 2.65 2.58 2.59 2.49
Support 2 (S2) 2.54 2.61 2.53 2.47
Support 3 (S3) 2.44 2.54 2.46
Support 4 (S4) 2.42